THRM Stock Analysis: Gentherm | NASDAQ

Climate Comfort, Pneumatic Comfort, Battery Thermal, Patient Warming

Total Rating 32

Safety 86

Buy Signal -0.79

Automotive Parts & Equipment
Sub-Industry Rotation: -4.0

Market Cap: 1.61B
Avg Turnover: 43.1M

Risk 3d forecast

Volatility39.8%

VaR 5^th Pctl6.27%

VaR vs Median-4.25%

Reward TTM

Sharpe Ratio-0.24

Rel. Str. IBD15

Rel. Str. Peer Group48.6 pctl

Character TTM

Beta1.049

Beta Downside1.405

Hurst Exponent0.398

Choppyness41.9%

Drawdowns 3y

Max DD60.59%

CAGR/Max DD-0.22

CAGR/Mean DD-0.40

EPS (Earnings per Share)

EPS CAGR: -4.04%
EPS Trend: -30.5%

Last SUE: -1.54
Qual. Beats: -1

Revenue

Rev. CAGR: 2.96%
Rev. Trend: 78.6%

Last SUE: 0.17
Qual. Beats: 0

Warnings

P/E Ratio 105.2

Below Avwap Earnings

Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.9 years of data, until 10/2026

Jan +0.4% 0

Feb +1.0% 14

Mar -2.0% 0

Apr -2.3% 4

May +2.5% 4

Jun +0.3% 0

Jul +9.1% 4

Aug -0.2% 0

Sep -7.2% 28

Oct -1.6% 0

Nov +7.4% 39

Dec -0.3% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: THRM Gentherm

Gentherm Incorporated is a U.S.-headquartered company that designs, develops, manufactures, and sells thermal management and pneumatic comfort technologies, operating through two business segments: Automotive and Medical. The company maintains a global manufacturing and sales footprint spanning the United States, China, Germany, the Czech Republic, South Korea, Mexico, Slovakia, Romania, Japan, and the United Kingdom. As a small-cap name in the GICS Automotive Parts & Equipment sub-industry, Gentherm functions primarily as a Tier 1 supplier selling directly to light vehicle original equipment manufacturers (OEMs).

The Automotive segment is the core of the business and includes climate comfort systems such as seat heaters, blowers, thermoelectric climate control seats, and steering wheel heaters, along with integrated electronic control units. The segment also covers pneumatic lumbar and massage comfort solutions, automotive cable technology for power distribution, battery performance solutions (cell connecting devices and battery cable technologies) for thermal management of various battery types, valve systems for brake and engine applications, and electronic and software systems for memory seat modules and other devices. Heated and ventilated seats are increasingly standard or optional in mid- to high-trim vehicles, particularly in colder climates, which has driven broader adoption of these comfort technologies across major OEM lineups.

The Medical segment provides patient temperature management systems marketed under the Blanketrol and Astotherm brands. These products are used for hyper-hypothermia therapy in intensive care settings, normothermia during surgical procedures, and additional warming and cooling therapies, serving hospitals and other medical industry customers.

The company was incorporated in 1991, originally under the name Amerigon Incorporated, and adopted the Gentherm name in September 2012. It is headquartered in Northville, Michigan, and trades on the NASDAQ under the ticker symbol THRM.

Headlines to Watch Out For

Battery thermal management wins drive automotive segment growth
Medical Blanketrol and Astotherm sales lift higher-margin segment
China manufacturing tariff risks pressure automotive margins

Piotroski VR-10 (Strict) 5.0

Net Income: 9.04m TTM > 0 and > 6% of Revenue
FCF/TA: 0.01 > 0.02 and ΔFCF/TA -3.62 > 1.0
NWC/Revenue: 29.76% < 20% (prev 26.25%; Δ 3.51% < -1%)
CFO/TA 0.04 > 3% & CFO 65.0m > Net Income 9.04m
Net Debt (169.0m) to EBITDA (106.9m): 1.58 < 3
Current Ratio: 2.05 > 1.5 & < 3
Outstanding Shares: last quarter (30.7m) vs 12m ago -0.25% < -2%
Gross Margin: 23.71% > 18% (prev 24.34%; Δ -0.63% > 0.5%)
Asset Turnover: 108.6% > 50% (prev 106.3%; Δ 2.23% > 0%)
Interest Coverage Ratio: 3.85 > 6 (EBIT TTM 48.8m / Interest Expense TTM 12.7m)

Altman Z'' 4.62

A: 0.30 (Total Current Assets 927.5m - Total Current Liabilities 451.9m) / Total Assets 1.56b
B: 0.46 (Retained Earnings 720.1m / Total Assets 1.56b)
C: 0.03 (EBIT TTM 48.8m / Avg Total Assets 1.47b)
D: 0.86 (Book Value of Equity 721.3m / Total Liabilities 841.0m)
Altman-Z'' = 4.62 = AA

Beneish M -2.99

DSRI: 0.92 (Receivables 326.2m/324.7m, Revenue 1.60b/1.47b)
GMI: 1.03 (GM 24.34% / 23.71%)
AQI: 1.02 (AQ_t 0.21 / AQ_t-1 0.20)
SGI: 1.09 (Revenue 1.60b / 1.47b)
TATA: -0.04 (NI 9.04m - CFO 65.0m) / TA 1.56b)
Beneish M = -2.99 (Cap -4..+1) = A

What is the price of THRM shares?

As of November 13, 2026, the stock is trading at USD 28.79 with a total of 516,113 shares traded. Over the past week, the price has changed by -2.82%, over one month by -6.89%, over three months by -25.92% and over the past year by -17.64%.

Current recommended Stop Loss: 26.80 (which is 6.9% or 1.2 ATR below the current price).

Is THRM a buy, sell or hold?

Gentherm has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy THRM.

StrongBuy: 5
Buy: 2
Hold: 2
Sell: 0
StrongSell: 0

What are the forecasts/targets for the THRM price?

Analysts Target Price	48	66.7%

Gentherm (THRM) - Fundamental Data Overview as of 10 November 2026

Market Cap USD = 1.61b (1.61b USD * 1.0 USD.USD)
P/E Trailing = 105.25
P/E Forward = 9.2678
P/S = 1.0048
P/B = 2.2256
P/EG = 1.0175
Revenue TTM = 1.60b USD
EBIT TTM = 48.8m USD
EBITDA TTM = 106.9m USD
Long Term Debt = 319.5m USD (from longTermDebt, last quarter)
Short Term Debt = 8.76m USD (from shortTermDebt, last quarter)
Debt = 421.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 50.3m
Net Debt = 169.0m USD (calculated: Debt 421.1m - CCE 252.1m)
Enterprise Value = 1.77b USD (1.61b + Debt 421.1m - CCE 252.1m)
Interest Coverage Ratio = 3.85 (Ebit TTM 48.8m / Interest Expense TTM 12.7m)
EV/FCF = 89.61x (Enterprise Value 1.77b / FCF TTM 19.8m)
FCF Yield = 1.12% (FCF TTM 19.8m / Enterprise Value 1.77b)
FCF Margin = 1.24% (FCF TTM 19.8m / Revenue TTM 1.60b)
Net Margin = 0.57% (Net Income TTM 9.04m / Revenue TTM 1.60b)
Gross Margin = 23.71% ((Revenue TTM 1.60b - Cost of Revenue TTM 1.22b) / Revenue TTM)
Gross Margin QoQ = 23.28% (prev 23.17%)
Tobins Q-Ratio = 1.14 (Enterprise Value 1.77b / Total Assets 1.56b)
Interest Expense / Debt = 3.01% (Interest Expense 12.7m / Debt 421.1m)
Taxrate = 48.97% (17.6m / 35.8m)
NOPAT = 24.9m (EBIT 48.8m * (1 - 48.97%))
Current Ratio = 2.05 (Total Current Assets 927.5m / Total Current Liabilities 451.9m)
Debt / Equity = 0.58 (Debt 421.1m / totalStockholderEquity, last quarter 721.3m)
Debt / EBITDA = 1.58 (Net Debt 169.0m / EBITDA 106.9m)
Debt / FCF = 8.53 (Net Debt 169.0m / FCF TTM 19.8m)
Total Stockholder Equity = 720.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.61% (Net Income 9.04m / Total Assets 1.56b)
RoE = 1.25% (Net Income TTM 9.04m / Total Stockholder Equity 720.3m)
RoCE = 4.69% (EBIT 48.8m / Capital Employed (Equity 720.3m + L.T.Debt 319.5m))
RoIC = 2.39% (NOPAT 24.9m / Invested Capital 1.04b)
WACC = 7.58% (E(1.61b)/V(2.03b) * Re(9.16%) + D(421.1m)/V(2.03b) * Rd(3.01%) * (1-Tc(0.49)))
Discount Rate = 9.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -71.12 | Cagr: -1.47%
[DCF] Terminal Value 73.10% ; FCFF base≈38.9m ; Y1≈34.1m ; Y5≈27.6m
[DCF] Fair Price = 5.02 (EV 442.3m - Net Debt 169.0m = Equity 273.3m / Shares 54.5m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -30.52 | EPS CAGR: -4.04% | SUE: -1.54 | # QB: -1
Revenue Correlation: 78.64 | Revenue CAGR: 2.96% | SUE: 0.17 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.74 | Chg30d=+2.31% | Revisions=+25% | Analysts=3
EPS current Year (2026-12-31): EPS=2.50 | Chg30d=-13.97% | Revisions=-62% | GrowthEPS=+10.0% | GrowthRev=+18.5%
EPS next Year (2027-12-31): EPS=3.09 | Chg30d=-4.55% | Revisions=-62% | GrowthEPS=+23.9% | GrowthRev=+59.8%
[Analyst] Revisions Ratio: -64% (up=1, down=10)